Carbapenemase-producing Enterobacteriaceae (CPE) Affects Hospital Patients

carbapenemase producing enterobacteriaceae CPE in healthcare

The news has carried several reports of drug-resistant bacteria in the past year or so. This was brought into sharp focus last year when four patients at a UK hospital, the Manchester Royal Infirmary were discovered to have the superbug known as carbapenemase-producing enterobacteriaceae, known for short as CPE.

While the resistance of bacteria to antibiotics is obviously a concern, the media has not clarified that CPE can be found behind every case that has made the headlines so far.

Four hospital patients taken into isolation

A regular healthcare screening process that took place at the Manchester Royal Infirmary highlighted the four cases mentioned above. The four affected patients were put in isolation and preventative action was taken accordingly.

What is carbapenemase-producing enterobacteriaceae?

Carbapenemase-producing enterobacteriaceae is a type of bacteria that has become resistant to the use of antibiotics. Not all forms of enterobacteriaceae are harmful to humans. Some exist in the gut and cause no harm at all. However, others are capable of causing food poisoning. The bacteria may also cause problems if they travel to other parts of the body.

The reason CPE has its name is because the bacteria produce carbapenemase. This is an enzyme that combats the use of the strongest antibiotics, which are known as carbapenems.

Only those who suffer from serious infections are likely to be prescribed these antibiotics. As such, if someone is affected by CPE and the antibiotics normally used to combat it do not work, this could leave the person in a potentially serious situation.

Cases of CPE are increasing

Back in 2006, only five people were found to have contracted CPE. However, just seven years later the figure had soared to more than 1,000. Fast-forward another year and around 1,600 people were affected.

A significant proportion of people with CPE were found to be affected by an outbreak in the Greater Manchester area of the United Kingdom. However, while cases do not seem to have spread at the present time, it is clearly concerning.

Preventing the spread of CPE

Public Health England has acted quickly to try and prevent CPE spreading throughout the population. Some people can carry the bacteria without being affected, while others develop infections because of it.

The challenge for Public Health England, hospital trusts and healthcare professionals is to manage and contain CPE and to prevent its spread.

Early detection is also crucial in preventing cases from getting worse and bacteria spreading to other people. Public Health England aims to make sure the bacteria is not allowed to get out of control.

Expert legionella & waterborne pathogen assistance

To find out more about the control of Legionella, Pseudomonas, Carbapenemase-producing enterobacteriaceae and other waterborne pathogens please contact us on 0161 877 0586 (Manchester) or 0203 637 47 48 (London).

London Office
Kemp House
152 City Road
London EC1V 2NX
United Kingdom
Tel: +44 (0) 203 637 47 48
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Manchester Office
Unit B Badex Building
Westbrook Park
Manchester M17 1AY
United Kingdom
Tel: +44 (0) 161 877 0586
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Further reading

For additional information about carbapenemase-producing enterobacteriaceae or CPE … here

 

Get in touch...

Legionella Control International
Unit B Badex Building
Westbrook Park
Manchester M17 1AY
United Kingdom

Manchester: +44 (0) 161 877 05 86
London: +44 (0) 203 637 47 48
Email: info@legionellacontrol.com

Eliminate uncertainty, mitigate your risk now…

Contact Us Today

Legionella Control International is trusted by clients worldwide...